Phase Ib trial of peginterferon beta
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2011
At a glance
- Drugs Peginterferon beta (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 18 Oct 2011 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2011 Interim adverse events, pharmacokinetics and pharmacodynamics data from a phase Ib trial in volunteers released by Allozyne.
- 12 Jan 2011 Results from this trial are expected in mid-2011.